AU Patent

AU2019253791B2 — Pharmaceutical composition, methods for treating and uses thereof

Assigned to Boehringer Ingelheim International GmbH · Expires 2021-09-16 · 5y expired

What this patent protects

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF ABSTRACT The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with …

USPTO Abstract

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF ABSTRACT The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019253791B2
Jurisdiction
AU
Classification
—
Expires
2021-09-16
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.